INTRODUCTION
Fluence-to-dose conversion coefficients are used to estimate doses produced by an external radiation field. There are published coefficients for photons, neutrons and light ions, based on a variety of radiation transport codes and phantoms (1 -6) . Improvements in computer technology and in Monte Carlo transport codes have facilitated Monte Carlo calculation of conversion coefficients for the heaviest of the light ions (deuterons, tritons, helions, and alpha particles), over a wide range of energies. Tritons ( 3 H þ ) are present in secondary galactic cosmic radiation in space and in the atmosphere at high altitudes and will contribute to the radiation doses received by astronauts and persons flying at high altitudes (7) . To estimate the risk of stochastic effects, the International Commission on Radiological Protection (ICRP) recommends effective dose as a radiation protection quantity for general application, including aviation at high altitudes and space exploration (8) . To express limits for deterministic effects and to calculate effective dose, ICRP uses equivalent doses to specific tissues. Gray equivalent is recommended by the National Council on Radiation Protection and Measurements (NCRP) to estimate deterministic effects in space applications (7, 9, 10) . Presented here are fluence-to-absorbed dose (Gy . cm 2 ), fluence-to-equivalent dose (Sv . cm 2 ), fluence-to-effective dose (Sv . cm 2 ) and fluence-to-gray equivalent (Gy-Eq . cm 2 ) conversion coefficients for isotropic exposure to tritons in the energy range of 10 MeV to 1 TeV (0.01 -1000 GeV).
METHODS

Radiation transport
Monte Carlo radiation transport code MCNPX 2.7.C (11) , with additional cross-sectional libraries distributed with MCNPX 2.6.0 (12) , were used to simulate isotropic exposure of an adult female and an adult male to tritons with energies from 10 MeV to 1 TeV. Energies were spaced approximately evenly in log(E) (i.e., 1, 2, 3, 5) . Particles selected for secondary transport were light ions (deuterons, tritons, helions and alpha particles), protons, neutrons, pions, kaons, photons, electrons, muons, tauons and neutrinos. Physics models in MCNPX were selected such that for interactions at energies above those in the tables, the most modern models available were used: LAQGSM 3.02 for light ion transport .0.940 GeV/nucleon and for protons and neutrons; FLUKA89 for anti-nucleons and kaons .0.800 GeV; ISABEL for anti-nucleons and kaons ,0.800 GeV; CEM 3.02 for other transport (11, 12) .
Anthropomorphic phantoms
For consistency with previously published coefficients for alpha particles and iron ions (13, 14) , modified BodyBuilder TM version 1.3 (15) phantoms, which are based on models described by Cristy and Eckerman (16) were used. For a complete list of changes made to the phantoms, see ref. (12) . The important assumptions and reasons for accepting them were the following.
(1) The oral mucosa dose was also used as the dose to the salivary glands. (2) The dose to muscle was used as the dose to lymph nodes, since lymph nodes and muscle are distributed similarly in the body. (3) The dose to female breasts was used as the dose to male breasts, since the male phantom has no breasts. This procedure was used in ICRP Publication 74 (1) and is discussed in ref. (8) (p. 274). (4) The dose to a whole bone was used as the dose to the bone surface and any red bone marrow within, since the phantoms do not differentiate between bone surface and interior. The approximations for bone and red bone marrow were tested using a simple cylindrically symmetric model (cortical bone surrounding adipose tissue beneath 5 cm of muscle) and found to be reasonable (less than a 10 % difference in results) at the energies used in the study. In all cases, material compositions were from ICRU Report 49 (17) . (5) A weighted average of doses to bones containing red bone marrow was used as the dose to red bone marrow. Weighting factors used were estimated fractions of red bone marrow in the bones of an adult (18) . (In the source for the red bone marrow distribution, the data were rounded to the nearest per cent and the percentages summed to 99. Thus, the fractions used were: sternum Results with a CV .0.1 were considered unreliable and not reported (12) . (6) The dose to the head skin was used as the dose to the eye lens because the phantoms lacked eyes and they are both thin tissues at or near the surface of the head.
Calculation of conversion coefficients
With minor differences, the methods used to calculate coefficients were as described in refs (13, 14) . The general steps and assumptions were the following:
(1) For each primary particle energy and tissue in Tables 1 and 2 , a fluence-to-absorbed dose conversion coefficient and coefficient of variation (CV, standard deviation divided by mean) were calculated. Calculations were stopped if either 5.00Eþ07 simulations were run or the largest CV for all tissues became less than 0.01. (2) For each primary particle energy in Table 3 , fluence-to-equivalent dose conversion coefficients were calculated by multiplying fluence-to-absorbed dose conversion coefficients by a radiation weighting factor (w R ) of 2. No w R is specified for tritons by ICRP (8) . However, for protons and charged pions externally incident on the body, ICRP recommends a w R of 2 in the energy range considered here (0.01-1000 GeV) (8) . The w R value is a function of LET and track structure and represents radiation quality averaged over the different tissues and organs of the body (8) . Protons, charged pions and tritons have the same charge and thus similar Results with a CV .0.1 were considered unreliable and not reported (12) .
LETs and track structures when traveling at the same speed. Indeed, Sato et al. (19) found that in the energy range of 0.005-3 GeV per nucleon, the average radiation quality factors for tritons and protons are similar, with both close to 2. Based on these considerations, the w R of 2 used in this report for tritons was considered reasonable. (3) For each primary particle energy in Table 4 , fluence-to-effective dose conversion coefficients were calculated from fluence-to-equivalent dose conversion coefficients. (4) For each primary particle energy and tissue in Table 5 , the sex-averaged fluence-to-gray equivalent conversion coefficients were calculated from the fluence-to-absorbed dose conversion coefficients by multiplying the fluence-to-absorbed dose conversion coefficient by an RBE of 1.5 (9) . The NCRP does not recommend an RBE for tritons. The RBE for protons was applied to tritons based on the same considerations presented in the earlier discussion of w R .
Calculation of coefficients of variation
As noted in the preceding section, CVs for the fluence-to-absorbed dose conversion coefficients were calculated for each tissue in each sex. The CVs reflect the repeatability of the calculation. CVs for the fluence-to-equivalent dose conversion coefficients are numerically the same as those calculated for the fluence-to-absorbed dose conversion coefficients. Except for breasts, when calculating a CV for a sexaveraged fluence-to-equivalent dose conversion coefficient, the dose to each sex was assumed to be independent. The formula used to sex-average the CVs is shown in the footnote to Table 3 . For breasts, the female CVs were used.
At each energy, a CV for each fluence-to-effective dose conversion coefficient was calculated using the CVs calculated for the sex-averaged fluence-to-equivalent dose conversion coefficients for the tissues, assuming independence of doses to each tissue. The formula used to calculate CV for each fluence-toeffective dose conversion coefficient is in the first footnote to Table 4. A CV for each whole-body fluence-to-gray equivalent conversion coefficient was calculated in the same manner as the corresponding fluence-to-effective dose conversion coefficient of the same energy, except that tissue weighting factors were replaced with the fractions of total body mass.
RESULTS
Fluence-to-absorbed dose conversion coefficients for tissues in female and male phantoms are shown in Tables 1 and 2 , respectively. Table 3 shows sexaveraged fluence-to-equivalent dose conversion coefficients for skin and eye lens. Table 4 shows fluence-to-effective dose conversion coefficients for a Reference Person, an adult female and an adult male, calculated using ICRP 2007 recommended tissues and tissue weighting factors (8) . Table 5 shows sex-averaged fluence-to-gray equivalent conversion coefficients for bone marrow, eye lens, skin and the whole body. Figure 1 shows: (a) (circles) sex-averaged fluenceto-effective dose conversion coefficients from Table 4 ; (b) (triangles) coefficients reported by Sato et al. (5) , who used a modified MIRD5 phantom (16) , ICRP 1990 recommended tissues and tissue weighting factors (20) , a w R of 20, the PHITS transport code (21) for light ions, heavy ions and hadrons (except low-energy neutrons), the MCNP4C transport code (22) for low-energy neutrons, and the EGS4 transport code (23) for photons, electrons and positrons; and (c) (crosses) coefficients obtained by modifying the methods of this report to incorporate 
5C S , where C S is the fluence-to-equivalent dose conversion coefficient for sex S (S¼female or male) and CV S is the CV of C S (from MCNPX).
FLUENCE-TO-DOSE CONVERSION: TRITONS
ICRP 1990 recommended tissues and tissue weighting factors (20) . In the figure, coefficients reported by Sato et al. (5) were divided by 10 to reduce their w R to 2, as was used in this report.
At 15 of the 19 energies for which coefficients for effective dose were calculated, coefficients based on ICRP 2007 and 1990 recommendations (circles and crosses) differed by less than 3 %. The greatest difference, 43 %, occurred at 30 MeV.
CONCLUSIONS
Using Monte Carlo methods, fluence-to-dose conversion coefficients for isotropic exposure to tritons in the energy range of 10 MeV to 1 TeV (0.01 -1000 GeV) were calculated for absorbed dose, equivalent dose, effective dose and gray equivalent. The energy range of coefficients for converting isotropic exposure to tritons to effective dose was extended from 9 GeV (5) to 1 TeV. After adjustment for use of different values of w R , where energies are similar to the fluence-to-effective dose conversion coefficients of this report agree well with those previously published by Sato et al (5) . With regard to tissues and tissue weighting factors, the use of ICRP 2007 recommendations instead of ICRP 1990 recommendations made little difference, except at very low energies. The primary cause of differences in coefficients at these energies was the difference in tissue weighting factors for breast (ICRP 2007 w T ¼0.12 vs. ICRP 1990 w T ¼0.05). The pattern of changes in coefficients with respect to energy for tritons was consistent with the pattern for protons reported by Sato et al (6) . As part of a larger set that includes recently published coefficients for heavy ions (13, 14, 24) , the presented coefficients will facilitate dose estimates during air and space travel. They will also be useful for comparisons of coefficients and doses calculated with the popular, but older, MIRD style phantoms with those calculated using the newer voxel phantoms recently adopted by the ICRP (25) . Using the fluence-to-absorbed dose conversion coefficients, a different radiation weighting factor 
where C T is the fluence-to-equivalent dose conversion coefficient for tissue T (see section Methods), CV T is the coefficient of variation (from MCNPX) of C T and w T is the ICRP 2007 recommended weighting factor for tissue T. and/or RBE for tritons can be substituted to calculate revised coefficients for equivalent dose, effective dose and gray equivalent. Canada, granted access to the High Performance 
, who used ICRP 1990 recommended tissues and tissue weighting factors (20) ; and (c) the method in this report modified to use ICRP 1990 recommended tissues and tissue weighting factors. A radiation weighting factor of 2 was applied to all three data setsSato et al. used a radiation weighting factor of 20, thus data they reported are 10 times larger than shown here. Plotted points are in the centre of the symbols. Size of the symbol for each point is unrelated to and much larger than the CV of the plotted data.
